Skip to main content
. 1999 Jun;1(2):118–122. doi: 10.1038/sj.neo.7900019

Table 2.

Treatment Characteristics of Patients Receiving Cyclosporin A.

No. of Patients

Number of treatment courses with CSA
1 2
2 10
≥3 28
Associated chemotherapy
Agents
Platinum 35
Taxol 3
Taxol/platinum 1
Etoposide/platinum 1

(CSA, cyclosporin A).